| Similar Articles |
|---|
 |
The Motley Fool
October 31, 2007
Brian Lawler |
Adams On-and-Off With the FDA A new compound gets delayed, but the drugmaker still raises earnings guidance, and shares rise. Investors, take note.   |
The Motley Fool
August 25, 2006
Ralph Casale |
Adams Coughs Up Some Profits Adams Respiratory Therapeutics isn't suffering any off-seasonal ills. Investors, take note. |
The Motley Fool
December 11, 2007
Brian Orelli |
Mucous Migrates East U.K.-based Reckitt Benckiser purchases Adams Respiratory Therapeutics, makers of Mucinex, for $2.3 billion. |
The Motley Fool
February 16, 2010
Brian Orelli |
For Blockbuster Cancer Drugs, Approvals Are the Easy Part Don't get too excited. As an investor, you can lower your risk by investing in cancer drug companies after a clinical trial success but before an FDA approval, but you'll also reduce your reward. |
The Motley Fool
December 31, 2010
Brian Orelli |
2010 FDA Approvals and a Look Ahead Recent history can help us handicap FDA decisions. |
The Motley Fool
March 8, 2010
Brian Orelli |
Really? A 59% Share Price Jump for That? Justified or not, InterMune skyrockets ahead of an FDA panel meeting. |
American Family Physician
October 1, 2004 |
Flu and Colds A general overview on the difference between colds and flu and how to treat the symptoms of both. |
The Motley Fool
September 15, 2010
Brian Orelli |
Cell Therapeutics Goes for Broke If Cell Therapeutics can't get new funding soon, long-term consequences may be the least of its worries; time on the clock looks to be running out. |
The Motley Fool
January 28, 2011
Brian Orelli |
Value Investing, Biotech Style Biotech investors should regard every binary event as a varying degree of confidence in a positive or negative result. |
The Motley Fool
May 27, 2011
Brian Orelli |
What Kind of Phase 2 Drug Can You Get for $5 Million? Cell Therapeutics issues a press release saying the company has identified a potential acquisition opportunity that is a phase II drug candidate. |
The Motley Fool
May 4, 2011
Brian Orelli |
Cell Therapeutics: Denied but Not Rejected Cell Therapeutics' ball may be headed for the end zone, but the FDA has an eight-foot free safety ready to bat it down. |
The Motley Fool
June 2, 2011
Luke Timmerman |
Infinity Dares to Think Big Against Pancreatic Cancer, Prepares to Show Early Results This Weekend Infinity Pharmaceuticals' top execs sometimes get strange looks when they say they are developing a new drug for pancreatic cancer. Is this a smart use of the company's time and resources? |
American Family Physician
February 15, 2007
Simasek & Blandino |
Treatment of the Common Cold The common cold is a viral illness that affects persons of all ages, prompting frequent use of over-the-counter and prescription medications and alternative remedies. This article helps you sift through all the medications. |
HBS Working Knowledge
September 24, 2007
Sean Silverthorne |
The FDA: What Will the Next 100 Years Bring? The challenge for FDA leaders is to maintain morale and focus, and to back up decisions with solid data on benefits and risks to different consumer populations. |
American Family Physician
May 1, 2004
Holmes & Fadden |
Evaluation of the Patient with Chronic Cough Diagnostic and treatment options for adults and children with chronic coughs. |
Nurse Practitioner
November 2009
Ann Marie Hart |
Treatment Strategies for Cough Illnesses in Adults Adults who experience a cough for 2 or more weeks along with vomiting or an inspiratory whooping sound should be evaluated and tested for B. pertussis infection. |
American Family Physician
May 15, 2004 |
Chronic Cough: Causes and Cures On overview on chronic coughs, their causes and cures. |
American Family Physician
August 1, 2006 |
Whooping Cough: What You Should Know A patient guide: What is whooping cough?... What causes it?... What should I do if I have whooping cough?... Where can I get more information?... etc. |
Pharmaceutical Executive
April 1, 2007
Joleen Schultz |
Marketing to Professionals: Everyone's a Comedian An ad campaign doesn't have to be "ha-ha" funny to sell a drug, but it doesn't hurt. |
